What does CUSIP 88338H100 represent in this 13F holders report?

CUSIP 88338H100 is the security identifier for THTX - THERATECHNOLOGIES INC - COM used to aggregate holder disclosures.

How many institutions held THTX - THERATECHNOLOGIES INC - COM in Q3 2024?

1 institutional investor reported THTX - THERATECHNOLOGIES INC - COM for Q3 2024. Use the holders table for investor-level position and value details.

THERATECHNOLOGIES INC - COM (THTX)

CUSIP: 88338H100

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / COM
Total 13F shares: 29,242
Share change: 0
Total reported value: $36,260
Price per share: $1.24
Number of holders: 1

Quarterly Holders Quick Answers

What is CUSIP 88338H100?
CUSIP 88338H100 identifies THTX - THERATECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP 88338H100:

Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

Institutional Holders of THERATECHNOLOGIES INC - COM (THTX) as of Q3 2024

As of 30 Sep 2024, THERATECHNOLOGIES INC - COM (THTX) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 29,242 shares. The largest 1 holders included MAI Capital Management. This page lists 1 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.